Nayan J. Patel

FDA investigator

Appears on 11 documents from 2017 to 2023, most often at sites in Utah. Most often cites general requirements (21 CFR 211.160).

11
Documents on file
3.0
Observations per 483
2017
First seen
2023
Most recent

What they cite most

From 33 observations

Activity by year

2017: 2, 2018: 3, 2019: 3, 2020: 2, 2023: 1

Where

Utah 3 · Colorado 2 · Arizona 1 · California 1 · India 1 · Montana 1

Is Nayan J. Patel coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

11 documents, newest first
FirmOpen
483 Genentech, Inc.Feb 2, 2023 · South San Francisco, California
483 Front Range Laboratories, IncorporatedMar 20, 2020 · Loveland, Colorado
483 Ultradent Products, Inc.Jan 17, 2020 · South Jordan, Utah
483 AIRGAS USA, LLCOct 25, 2019 · Salt Lake City, Utah
483 Yusef Manufacturing Laboratories, LLCSep 13, 2019 · Clearfield, Utah
483 Corden Pharma Boulder, Inc.Feb 6, 2019 · Boulder, Colorado
483 Matrix Pharmacorp Private LimitedDec 10, 2018 · Vizianagaram, India

About this profile

What does Nayan J. Patel inspect?

Nayan J. Patel appears on 11 documents on file covering 11 sites, most often in Utah.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.113 and 21 CFR 211.165(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Nayan J. Patel is dated Feb 2, 2023.